SCHEMBL27617099

SCHEMBL27617099

CC(C)C1CCC(N)(CC(=O)O)CC1

nearest known ligand 0.36

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.36
POLB P06746 1/20 0.35
OPRL1 P41146 3/20 0.34
ALDH1A1 P00352 3/20 0.32
TSHR P16473 2/20 0.32
LMNA P02545 2/20 0.32
USP2 O75604 1/20 0.32
BLM P54132 1/20 0.32
CACNA2D1 P54289 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CYP2C19 P33261 1/20 0.31
OPRM1 P35372 1/20 0.30
GRM1 Q13255 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27637708 0.81 POLB (0.37) CYP1A2POLBALDH1A1TSHRLMNA
SCHEMBL28777690 0.79 CYP1A2 (0.37) CYP1A2OPRL1ALDH1A1TSHRLMNA
SCHEMBL8200036 0.79 ALDH1A1 (0.55) CYP1A2POLBOPRL1ALDH1A1TSHR
SCHEMBL26255 0.79 ALDH1A1 (0.55) CYP1A2POLBOPRL1ALDH1A1TSHR
SCHEMBL1764007 0.76 CYP1A2 (0.36) CYP1A2POLBALDH1A1TSHRLMNA
SCHEMBL4115624 0.75
SCHEMBL5440202 0.73 ALDH1A1 (0.47) CYP1A2POLBALDH1A1TSHRLMNA
SCHEMBL5440200 0.73 ALDH1A1 (0.47) CYP1A2POLBALDH1A1TSHRLMNA
SCHEMBL5441678 0.73 ALDH1A1 (0.47) CYP1A2POLBALDH1A1TSHRLMNA
SCHEMBL5437232 0.73 ALDH1A1 (0.47) CYP1A2POLBALDH1A1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1626069-A Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy WARNER LAMBERT CO (US) 2005-06-15 CN claimed
CN-1626069-A Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy WARNER LAMBERT CO (US) 2005-06-15 CN disclosed